# Intralesional Bleomycin Sclerotherapy for Low-Flow Vascular Malformations of the Head and Neck

> **NCT07728825** · PHASE4 · COMPLETED · sponsor: **University Of Anbar** · enrollment: 20 (actual)

## Conditions studied

- Vascular Malformations
- Venous Malformation
- Lymphatic Malformation

## Interventions

- **DRUG:** Bleomycin (Bleocel 15)

## Key facts

- **NCT ID:** NCT07728825
- **Lead sponsor:** University Of Anbar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-25
- **Primary completion:** 2026-04-16
- **Final completion:** 2026-04-26
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07728825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07728825, "Intralesional Bleomycin Sclerotherapy for Low-Flow Vascular Malformations of the Head and Neck". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07728825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*